BFRI
Biofrontera Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
1.30
close · 2026-08-14
value
95
cheaper than peers95
quality
11
stronger fundamentals11
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
35 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 0.39× | 98 |
| forward P/E | 4.06× | 91 |
| price to book | 2.54× | 68 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 17.4% | 74 |
| debt to equity | 127.2% | 35 |
| operating margin | -39.0% | 7 |
| return on equity | -339.0% | 2 |
4 of 4 measures available
Facts
| market cap | $17M |
| free cash flow | $1.5M |
| employees | 84 |
| first trade | 2021-10-29 |
| next earnings | 2026-08-13 |
| fundamentals updated | 2026-08-14 |